{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:36:58Z","timestamp":1790851018658,"version":"4.1.0"},"reference-count":38,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"4671","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1984,10,12]]},"abstract":"<jats:p>A recently discovered member of the human T-cell leukemia virus (HTLV) family of retroviruses has been etiologically linked to the acquired immune deficiency syndrome (AIDS). This virus, which has been designated HTLV-III, is tropic for OKT4-bearing (helper-inducer) T cells. Moreover, the virus is cytopathic for these cells. Suramin is a drug used in the therapy of Rhodesian trypanosomiasis and onchocerciasis, and it is known to inhibit the reverse transcriptase of a number of retroviruses. Suramin has now been found to block in vitro the infectivity and cytopathic effect of HTLV-III at doses that are clinically attainable in human beings.<\/jats:p>","DOI":"10.1126\/science.6091268","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T19:41:59Z","timestamp":1160077319000},"page":"172-174","source":"Crossref","is-referenced-by-count":312,"title":["Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-III"],"prefix":"10.1126","volume":"226","author":[{"given":"Hiroaki","family":"Mitsuya","sequence":"first","affiliation":[{"name":"Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikulas","family":"Popovic","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland 20205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Yarchoan","sequence":"additional","affiliation":[{"name":"Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Gallo","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Cell Biology, National Cancer Institute, Bethesda, Maryland 20205"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Broder","sequence":"additional","affiliation":[{"name":"Clinical Oncology Program, National Cancer Institute, Bethesda, Maryland 20205"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","first-page":"248","volume":"306","year":"1982","unstructured":"NEW ENGLAND JOURNAL OF MEDICINE 306: 248 (1982).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_2_1","unstructured":"ARTHUR L unpublished data."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/2261209a0"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6189183"},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0304-3835(79)90017-X","volume":"8","year":"1979","unstructured":"DECLERCQ, E, SURAMIN - POTENT INHIBITOR OF THE REVERSE-TRANSCRIPTASE OF RNA TUMOR-VIRUSES, CANCER LETTERS 8: 9 (1979).","journal-title":"CANCER LETTERS"},{"key":"e_1_2_1_6_1","first-page":"157","volume":"39","year":"1968","unstructured":"DUKE, BOL, EFFECTS OF DRUGS ON ONCHOCERCA VOLVULUS .3. TRIALS OF SURAMIN AT DIFFERENT DOSAGES AND A COMPARISON OF BRANDS ANTRYPOL MORANYL AND NAGANOL, BULLETIN OF THE WORLD HEALTH ORGANIZATION 39: 157 (1968).","journal-title":"BULLETIN OF THE WORLD HEALTH ORGANIZATION"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6342136"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6603659"},{"key":"e_1_2_1_9_1","first-page":"698","volume":"2","year":"1983","unstructured":"EVATT, B.L., ANTIBODIES TO HUMAN T-CELL LEUKEMIA VIRUS-ASSOCIATED MEMBRANE-ANTIGENS IN HEMOPHILIACS - EVIDENCE FOR INFECTION BEFORE 1980, LANCET 2: 698 (1983).","journal-title":"LANCET"},{"key":"e_1_2_1_10_1","first-page":"305","volume":"30","year":"1981","unstructured":"FRIEDMANKIEN, A, MORBIDITY AND MORTALITY WEEKLY REPORT 30: 305 (1981).","journal-title":"MORBIDITY AND MORTALITY WEEKLY REPORT"},{"issue":"298","key":"e_1_2_1_11_1","first-page":"54","year":"1974","unstructured":"Fuglsang, H., Scientific publication of the Pan American Health Organization 298: 54 (1974).","journal-title":"Scientific publication of the Pan American Health Organization"},{"key":"e_1_2_1_12_1","first-page":"113","volume":"3","year":"1984","unstructured":"GALLO, R. C., CANCER SURVEYS 3: 113 (1984).","journal-title":"CANCER SURVEYS"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6601823"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6200936"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6601822"},{"key":"e_1_2_1_16_1","first-page":"250","volume":"30","year":"1981","unstructured":"GOTTLIEB, M.S., MORBIDITY AND MORTALITY WEEKLY REPORT 30: 250 (1981).","journal-title":"MORBIDITY AND MORTALITY WEEKLY REPORT"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112103052401"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1054-3589(08)60486-X","volume":"15","year":"1978","unstructured":"Hawking, F., Advances in Pharmacology and Chemotherapy 15: 289 (1978).","journal-title":"Advances in Pharmacology and Chemotherapy"},{"key":"e_1_2_1_19_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0035-9203(40)90088-8","volume":"34","year":"1940","unstructured":"HAWKING, F, T R SOC TROP MED HYG 34: 37 (1940).","journal-title":"T R SOC TROP MED HYG"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112103052402"},{"key":"e_1_2_1_21_1","unstructured":"MATSUSHITA S unpublished data."},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1126\/science.6206569","volume":"225","year":"1984","unstructured":"MITSUYA, H, FUNCTIONAL-PROPERTIES OF ANTIGEN-SPECIFIC T-CELLS INFECTED BY HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS (HTLV-I), SCIENCE 225: 1484 (1984).","journal-title":"SCIENCE"},{"key":"e_1_2_1_23_1","first-page":"728","volume":"309","year":"1984","unstructured":"PATARCA, R, SEQUENCE SIMILARITY AMONG RETROVIRUSES, NATURE 309: 728 (1984).","journal-title":"NATURE"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/294268a0"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.12.7415"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6200935"},{"key":"e_1_2_1_27_1","unstructured":"SALAHUDDIN S.Z. unpublished data."},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6324345"},{"key":"e_1_2_1_29_1","first-page":"531","volume":"16","year":"1957","unstructured":"SATTI, M.H., BULLETIN OF THE WORLD HEALTH ORGANIZATION 16: 531 (1957).","journal-title":"BULLETIN OF THE WORLD HEALTH ORGANIZATION"},{"key":"e_1_2_1_30_1","first-page":"302","volume":"1","year":"1984","unstructured":"SCHUPBACH, J, DEMONSTRATION OF VIRAL ANTIGEN-P24 IN CIRCULATING IMMUNE-COMPLEXES OF 2 PATIENTS WITH HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS (HTLV) POSITIVE LYMPHOMA, LANCET 1: 302 (1984).","journal-title":"LANCET"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6200937"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6324349"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198112103052403"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/2261211a0"},{"key":"e_1_2_1_35_1","first-page":"163","volume":"236","year":"1972","unstructured":"TING, R.C., REVERSE TRANSCRIPTASE, RNA TUMOR-VIRUS TRANSFORMATION AND DERIVATIVES OF RIFAMYCIN SV, NATURE-NEW BIOLOGY 236: 163 (1972).","journal-title":"NATURE-NEW BIOLOGY"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/305827a0","volume":"305","year":"1983","unstructured":"TOH, H, SEQUENCE HOMOLOGY BETWEEN RETROVIRAL REVERSE-TRANSCRIPTASE AND PUTATIVE POLYMERASES OF HEPATITIS-B VIRUS AND CAULIFLOWER MOSAIC-VIRUS, NATURE 305: 827 (1983).","journal-title":"NATURE"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/302626a0"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.6.2031"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.6091268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T16:24:02Z","timestamp":1705249442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.6091268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984,10,12]]},"references-count":38,"journal-issue":{"issue":"4671","published-print":{"date-parts":[[1984,10,12]]}},"alternative-id":["10.1126\/science.6091268"],"URL":"https:\/\/doi.org\/10.1126\/science.6091268","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1984,10,12]]}}}